Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Abstract 947: Effects of methadone on ovarian cancer cell-lines and patient-derived tumor-spheroids

Heidelinde Fiegl, Judith Hagenbuchner, Michael J. Ausserlechner, Christiana Kyvelidou, Beata Seeber, Sieghart Sopper, Irina Tsibulak, Verena Wieser, Julia Roessler, Elisabeth Reiser, Kaisa Huhtinen, Olli Carpén, Walther Parson, Christian Marth, Alain G. Zeimet

Cancer Res (2021) 81 (13_Supplement): 947.

https://doi.org/10.1158/1538-7445.AM2021-947

Published: 01 July 2021

View articletitled, Abstract 947: Effects of methadone on ovarian cancer cell-lines and patient-derived tumor-spheroids

Journal Articles

Abstract P5-12-01: SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)

Cancer Res (2020) 80 (4_Supplement): P5-12-01.

https://doi.org/10.1158/1538-7445.SABCS19-P5-12-01

Published: 15 February 2020

View articletitled, Abstract P5-12-01: SOLE (study of letrozole extension), a phase 3 randomized clinical trial of continuous vs intermittent letrozole in postmenopausal women who have received 4-6 years of adjuvant endocrine therapy for lymph node-positive, early breast cancer (BC): Final analysis and sole estrogen substudy (SOLE-EST)

Journal Articles

Abstract P6-08-23: Serum–based test to identify patients with early relapse treated with adjuvant hormonal therapy

Heidi Fiegl, Christian Marth, Krista Meyer, Julia Grigorieva, Heinrich Roder

Cancer Res (2015) 75 (9_Supplement): P6-08-23.

https://doi.org/10.1158/1538-7445.SABCS14-P6-08-23

Published: 01 May 2015

View articletitled, Abstract P6-08-23: Serum–based test to identify patients with early relapse treated with adjuvant hormonal therapy

Journal Articles

E2F3a Is Critically Involved in Epidermal Growth Factor Receptor–Directed Proliferation in Ovarian Cancer

Daniel Reimer, Michael Hubalek, Svenja Riedle, Sergej Skvortsov, Martin Erdel, Nicole Concin, Heidi Fiegl, Elisabeth Müller-Holzner, Christian Marth, Karl Illmensee, Peter Altevogt, Alain G. Zeimet

Cancer Res (2010) 70 (11): 4613–4623.

https://doi.org/10.1158/0008-5472.CAN-09-3551

Published: 01 June 2010

View articletitled, E2F3a Is Critically Involved in Epidermal Growth Factor Receptor–Directed Proliferation in Ovarian Cancer

Includes: Supplementary data

Journal Articles

FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer

Cancer Res (2007) 67 (19): 9006–9012.

https://doi.org/10.1158/0008-5472.CAN-07-1320

Published: 01 October 2007

View articletitled, FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer

Includes: Supplementary data

Journal Articles

Detection of Low Molecular Weight Derivatives of Cyclin E1 Is a Function of Cyclin E1 Protein Levels in Breast Cancer

Charles Spruck, Dahui Sun, Heidi Fiegl, Christian Marth, Elisabeth Mueller-Holzner, Georg Goebel, Martin Widschwendter, Steven I. Reed

Cancer Res (2006) 66 (14): 7355–7360.

https://doi.org/10.1158/0008-5472.CAN-05-3240

Published: 18 July 2006

View articletitled, Detection of Low Molecular Weight Derivatives of Cyclin E1 Is a Function of Cyclin E1 Protein Levels in Breast Cancer

Journal Articles

Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer

Heidi Fiegl, Simone Millinger, Georg Goebel, Elisabeth Müller-Holzner, Christian Marth, Peter W. Laird, Martin Widschwendter

Cancer Res (2006) 66 (1): 29–33.

https://doi.org/10.1158/0008-5472.CAN-05-2508

Published: 05 January 2006

View articletitled, Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer

Includes: Supplementary data

Journal Articles

Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients

Heidi Fiegl, Simone Millinger, Elisabeth Mueller-Holzner, Christian Marth, Christian Ensinger, Andreas Berger, Helmut Klocker, Georg Goebel, Martin Widschwendter

Cancer Res (2005) 65 (4): 1141–1145.

https://doi.org/10.1158/0008-5472.CAN-04-2438

Published: 25 February 2005

View articletitled, Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients

Includes: Supplementary data

Journal Articles

DNA Hypomethylation and Ovarian Cancer Biology

Martin Widschwendter, Guanchao Jiang, Christian Woods, Hannes M. Müller, Heidi Fiegl, Georg Goebel, Christian Marth, Elisabeth Müller-Holzner, Alain G. Zeimet, Peter W. Laird, Melanie Ehrlich

Cancer Res (2004) 64 (13): 4472–4480.

https://doi.org/10.1158/0008-5472.CAN-04-0238

Published: 01 July 2004

View articletitled, DNA Hypomethylation and Ovarian Cancer Biology

Includes: Supplementary data

Journal Articles

Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

Martin Widschwendter, Kimberly D. Siegmund, Hannes M. Müller, Heidi Fiegl, Christian Marth, Elisabeth Müller-Holzner, Peter A. Jones, Peter W. Laird

Cancer Res (2004) 64 (11): 3807–3813.

https://doi.org/10.1158/0008-5472.CAN-03-3852

Published: 01 June 2004

View articletitled, Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

Includes: Supplementary data

Journal Articles

Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo

Nicole Concin, Kirsten Becker, Neda Slade, Susan Erster, Elizabeth Mueller-Holzner, Hanno Ulmer, Guenter Daxenbichler, Alain Zeimet, Robert Zeillinger, Christian Marth, Ute M. Moll

Cancer Res (2004) 64 (7): 2449–2460.

https://doi.org/10.1158/0008-5472.CAN-03-1060

Published: 01 April 2004

View articletitled, Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo

Journal Articles

DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker

Hannes M. Müller, Andreas Widschwendter, Heidi Fiegl, Lennart Ivarsson, Georg Goebel, Elisabeth Perkmann, Christian Marth, Martin Widschwendter

Cancer Res (2003) 63 (22): 7641–7645.

Published: 21 November 2003

View articletitled, DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker

Includes: Supplementary data

Journal Articles

Calgranulins in Cystic Fluid and Serum from Patients with Ovarian Carcinomas

Helmut W. Ott, Herbert Lindner, Bettina Sarg, Elisabeth Mueller-Holzner, Burkhard Abendstein, Anton Bergant, Siegfried Fessler, Peter Schwaerzler, Alain Zeimet, Christian Marth, Karl Illmensee

Cancer Res (2003) 63 (21): 7507–7514.

Published: 11 November 2003

View articletitled, Calgranulins in Cystic Fluid and Serum from Patients with Ovarian Carcinomas

Journal Articles

hCDC4 Gene Mutations in Endometrial Cancer

Charles H. Spruck, Heimo Strohmaier, Olle Sangfelt, Hannes M. Müller, Michael Hubalek, Elisabeth Müller-Holzner, Christian Marth, Martin Widschwendter, Steven I. Reed

Cancer Res (2002) 62 (16): 4535–4539.

Published: 15 August 2002

View articletitled, hCDC4 Gene Mutations in Endometrial Cancer

Journal Articles

Loss of Retinoic Acid Receptor β Expression in Breast Cancer and Morphologically Normal Adjacent Tissue but not in the Normal Breast Tissue Distant from the Cancer

Martin Widschwendter, Jennifer Berger, Günter Daxenbichler, Elisabeth Müller-Holzner, Andreas Widschwendter, Adelcy Mayr, Christian Marth, Alain G. Zeimet

Cancer Res (1997) 57 (19): 4158–4161.

Published: 01 October 1997

View articletitled, Loss of Retinoic Acid Receptor β Expression in Breast Cancer and Morphologically Normal Adjacent Tissue but not in the Normal Breast Tissue Distant from the Cancer

Journal Articles

Effects of Retinoic Acid and γ-Interferon on Expression of Retinoic Acid Receptor and Cellular Retinoic Acid-binding Protein in Breast Cancer Cells

Martin Widschwendter, Günter Daxenbichler, Otto Dapunt, Christian Marth

Cancer Res (1995) 55 (10): 2135–2139.

Published: 01 May 1995

View articletitled, Effects of Retinoic Acid and γ-Interferon on Expression of Retinoic Acid Receptor and Cellular Retinoic Acid-binding Protein in Breast Cancer Cells

Journal Articles

γ-Interferon Reduces Expression of the Protooncogene c-erbB-2 in Human Ovarian Carcinoma Cells

Christian Marth, Elisabeth Müller-Holzner, Evi Greiter, Marcus V. Cronauer, Alain G. Zeimet, Wolfgang Doppler, Brigitte Eibl, Nancy E. Hynes, Günter Daxenbichler

Cancer Res (1990) 50 (21): 7037–7041.

Published: 01 November 1990

View articletitled, γ-Interferon Reduces Expression of the Protooncogene c-erbB-2 in Human Ovarian Carcinoma Cells

Journal Articles

Modulation of Ovarian Carcinoma Tumor Marker CA-125 by γ-Interferon

Christian Marth, Lothar C. Fuith, Günther Böck, Günter Daxenbichler, Otto Dapunt

Cancer Res (1989) 49 (23): 6538–6542.

Published: 01 December 1989

View articletitled, Modulation of Ovarian Carcinoma Tumor Marker CA-125 by γ-Interferon

Journal Articles

Effects of Human Recombinant α₂ arg-Interferon and γ-Interferon on Human Breast Cancer Cell Lines: Dissociation of Antiproliferative Activity and Induction of HLA-DR Antigen Expression

Günther Gastl, Christian Marth, Eva Leiter, Claus Gattringer, Inge Mayer, Günter Daxenbichler, Roswitha Flener, Christoph Huber

Cancer Res (1985) 45 (7): 2957–2961.

Published: 01 July 1985

View articletitled, Effects of Human Recombinant α2 arg-Interferon and γ-Interferon on Human Breast Cancer Cell Lines: Dissociation of Antiproliferative Activity and Induction of HLA-DR Antigen Expression

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 947: Effects of methadone on ovarian cancer cell-lines and patient-derived tumor-spheroids

Abstract P6-08-23: Serum–based test to identify patients with early relapse treated with adjuvant hormonal therapy

E2F3a Is Critically Involved in Epidermal Growth Factor Receptor–Directed Proliferation in Ovarian Cancer

FBXW7/hCDC4 Is a General Tumor Suppressor in Human Cancer

Detection of Low Molecular Weight Derivatives of Cyclin E1 Is a Function of Cyclin E1 Protein Levels in Breast Cancer

Breast Cancer DNA Methylation Profiles in Cancer Cells and Tumor Stroma: Association with HER-2/neu Status in Primary Breast Cancer

Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients

DNA Hypomethylation and Ovarian Cancer Biology

Association of Breast Cancer DNA Methylation Profiles with Hormone Receptor Status and Response to Tamoxifen

Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors in Vivo

DNA Methylation in Serum of Breast Cancer Patients: An Independent Prognostic Marker

Calgranulins in Cystic Fluid and Serum from Patients with Ovarian Carcinomas

hCDC4 Gene Mutations in Endometrial Cancer

Loss of Retinoic Acid Receptor β Expression in Breast Cancer and Morphologically Normal Adjacent Tissue but not in the Normal Breast Tissue Distant from the Cancer

Effects of Retinoic Acid and γ-Interferon on Expression of Retinoic Acid Receptor and Cellular Retinoic Acid-binding Protein in Breast Cancer Cells

γ-Interferon Reduces Expression of the Protooncogene c-erbB-2 in Human Ovarian Carcinoma Cells

Modulation of Ovarian Carcinoma Tumor Marker CA-125 by γ-Interferon

Effects of Human Recombinant α₂ arg-Interferon and γ-Interferon on Human Breast Cancer Cell Lines: Dissociation of Antiproliferative Activity and Induction of HLA-DR Antigen Expression

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only